发明名称 SULFONYLPYRAZOLE AND SULFONYLPYRAZOLINE CARBOXAMIDINE DERIVATIVES AS 5-HT6 ANTAGONISTS.
摘要 <p>This invention concerns sulfonylpyrazoline carboxamidine derivatives as antagonists of 5-HT6 receptors, to methods for the preparation of these compounds and to novel intermediates useful for their synthesis. The invention also relates to the uses of such compounds and compositions, particularly their use in administering them to patients to achieve a therapeutic effect in Parkinson's disease, Huntington's chorea, schizophrenia, anxiety, depression, manic depression, psychoses, epilepsy, obsessive compulsive disorders, mood disorders, migraine, Alzheimer's disease, age related cognitive decline, mild cognitive impairment, sleep disorders, eating disorders, anorexia, bulimia, binge eating disorders, panic attacks, akathisia, attention deficit hyperactivity disorder, attention deficit disorder, withdrawal from abuse of cocaine, ethanol, nicotine or benzodiazepines, pain, disorders associated with spinal trauma or head injury, hydrocephalus, functional bowel disorder, Irritable Bowel Syndrome, obesity and type-2 diabetes. The compounds have the general formula (1), wherein the symbols have the meanings given in the description.</p>
申请公布号 MX2009003183(A) 申请公布日期 2009.04.03
申请号 MX20090003183 申请日期 2007.09.20
申请人 SOLVAY PHARMACEUTICALS B.V. 发明人 ZORGDRAGER, JAN;KRUSE, CORNELIS G.;KEIZER, HISKIAS G.;IWEMA BAKKER, WOUTER I.;NEUT, VAN DER, MARTINA A.W.;LOEVEZIJN, VAN, ARNOLD
分类号 C07D231/06;A61K31/415;A61K31/4155;A61P25/00;C07D231/12;C07D401/04;C07D401/12;C07D403/12;C07D407/04;C07D409/12;C07D417/12;C07D513/04 主分类号 C07D231/06
代理机构 代理人
主权项
地址